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Background. Esophagectomy for esophageal cancer is being practiced routinely with favorable results at many centers. We sought
to determine if tumor histology is a powerful surrogate marker for perioperative morbidity. Methods.S e v e n t yt h r e ec o n s e c u t i v e
patients managed operatively were reviewed from our prospectively maintained database. Results. Adenocarcinoma (AC) was
present in 52 (71%) and squamous cell (SCC) in 21 (29%). The use of neoadjuvant therapy was similar for the AC (34.62%)
and SCC (42.86%) groups. The SCC group had a higher incidence of prior pulmonary disease than the AC group (23.8% versus
5.8%, resp.; P = .03). SCC patients were more likely to have a prolonged ICU stay than AC patients (P = .004) despite similar
complicationrates,EBL,andprognosticnutritionalindex.TheSCCgroupdid,however,experiencehighergradesofcomplications
(P = .0053). Conclusions. Presence of SCC was the single best predictor of prolonged ICU stay and more severe complications as
deﬁned by this study. Only a past history of pulmonary disease was diﬀerent between the two histologic subgroups.
Copyright © 2008 Charles E. Woodall et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Esophagectomy for esophageal cancer is being practiced rou-
tinely with favorable results at many centers. Improvements
in surgical technique and perioperative care have permitted
a procedure once associated with high mortality rates to
now be practiced with a low risk of postoperative death.
However, studies continue to report high morbidity and
there is now a focused eﬀort to identify factors that may
predict perioperative outcome.
Pulmonary complications are a major contributor to
mortality in esophageal cancer and eﬀorts to improve
pulmonary hygiene have contributed to reduced periop-
erative mortality [1]. As an adjunct to further decrease
these complications, the necessity of a thoracic incision
when performing esophagectomy has long been debated.
Proponents have often argued that its use enables a more
complete lymphadenectomy, while opponents feel it con-
tributes signiﬁcantly to perioperative morbidity but this has
not been shown to aﬀect long-term prognosis [2].
Given the importance of pulmonary status on outcome,
the ability to predict those patients at higher risk for
pulmonary complications might then be of some beneﬁt,
not only in predicting their potential for morbidity, but
also in choosing the approach that may mitigate these
risks. Many feel that a minimally invasive approach may be
the answer. Recently, investigators have reported promising
results with minimally invasive approaches [3, 4]. While
there is little debate regarding the role of surgical tech-
nique and comorbid conditions on the development of
postoperativecomplications,littleisknownabouttheimpact
of tumor biology on morbidity. Based on recent a report
suggesting that the esophageal histology may impact peri-
operative outcome [5], we sought to further delineate this
relationship.Thisstudyisanattempttorecognizethattumor
histology alone can identify patients more likely to suﬀer
a complication and perhaps guide perioperative decision
making.
2. Methods
The records of patients included in a prospectively main-
tained upper gastrointestinal malignancy database were
reviewed for this institutional review board approved study.2 Journal of Oncology
All patients undergoing esophagogastrectomy for esophageal
carcinomawereincludedinthestudy,andallpatientsunder-
went a standard combined thoracic and abdominal esoph-
agogastrectomy (Ivor-Lewis type) procedure. This review
was performed under an IRB approved protocol from the
University of Louisville Human Subjects Protection Oﬃce.
Allpatientshadundergonecompletepreoperativeevaluation
with CT chest/abdomen/ pelvis, endoscopic ultrasound, and
in some, PET scanning. Most patients with preoperative
T2 or greater, or N1 (by imaging) were given neoadjuvant
chemoradiation with either 5-ﬂuorouracil or combined 5
ﬂuorouracil with cisplatin depending on the histology of the
disease and standard radiation therapy dosing of 5040 cGy.
Operative techniques were consistent across this study with
the esophagogastrectomy performed through an abdominal
incision ﬁrst, with mobilization, celiac and supraceliac
lymphadenectomy, pyloroplasty, and gastric conduit for-
mation followed by a thoracic incision, with mobilization,
thoracic lymphadenectomy, tumor resection, and thoracic
anastomosis.
Variables evaluated included demographics (age, race,
and gender), smoking history, alcohol history, histology,
cancer staging, grade and type of complications, nutritional
status,lengthof intensive careunit stay, and operative factors
including estimated blood loss. Comorbidities, such as prior
cardiac and pulmonary disease as well as history of tobacco
and alcohol abuse as reported by the patient were also
recorded. The prognostic nutritional index (PNI) advocated
by Onodera et al. [6] was calculated to investigate the preop-
erative nutritional condition of the patients in both groups.
It is calculated from the formula (giving a percentage) (10
× Albumin) + (0.005 × absolute lymphocyte count). Prior
cardiac history was deﬁned as any patient with a history of
angina, previous coronary artery disease deﬁned by cardiac
catheterization,previousmyocardialinfarction,cardiacvalve
dysfunction requiring medication, or a history of congestive
heart failure or tachyarrhythmia. Prior pulmonary disease
history was deﬁned as any patient with abnormal pulmonary
function tests, history of asthma requiring daily meter dosed
inhalers, or tobacco use greater than a 25-pack year history.
All postoperative complications and the length of hos-
pital stay were prospectively entered into the database.
Complications were identiﬁed prospectively and assigned a
grade from 1 to 5 based on an established scale [7]. Examples
of the grading of complications includes (1) uncomplicated
urinary tract infection; (3) small, contained anastomotic
leak requiring no further operative therapy or drainage
procedures; (5) death. In instances where the grading was
unclear, a score was assigned after review of the records
and discussion between two of the senior authors. All
in hospital and 90-day postoperative complications were
evaluated with the most severe complication level recorded.
Infectious complications were deﬁned by a positive ﬂuid
(sputum, wound, urine, etc.) culture, with some criteria of a
systemic inﬂammatory response (i.e., tachycardia, fever, and
hypoxia)
Statistical analysis was performed with JMP software
(SAS Institute, Cary, NC, USA ). Analysis of variance, log-
rank analysis, and Pearson correlation coeﬃcient were used
Table 1: Adenocarcinoma and squamous cell carcinoma groups
patient demographics.
Adenocarcinoma,
n (%)
Squamous cell
carcinoma, n (%) P-value
n 52 (71%) 21 (29%)
Median age 59 63 .21
Caucasian race 44 (8462%) 10 (47.62%) .0004
Male gender 45 (86.54%) 10 (47.62%) .0007
Alcohol abuse 6 (11.54%) 8 (38.1%) .012
Tobacco use 36 (69.23%) 13 (61.9%) .5492
Prior cardiac
disease 13 (25%) 4 (19.05%) .573
Prior pulmonary
disease 3 (5.77%) 5 (23.81%) .034
FEV1 <75% 3 (5.77%) 4 (19%) .06
to determine signiﬁcance, and a P-value <.05 was considered
signiﬁcant in this study.
3. Results
Seventy three consecutive patients undergoing combined
abdominal and thoracic esophagogastrectomy for cancer
were identiﬁed and included in the study, with a median
age was 61 (range 26 to 80). 55 (75.3%) were male and 18
female (24.7%). Fifty four patients (74%) were Caucasian,
12 (16%) were African-American, and the race of 7 (9%)
was not recorded. There were 3 (4.1%) perioperative deaths,
all occurring in the AC group. Adenocarcinoma (AC) was
presentin52(71%)andsquamouscell(SCC)in21(29%).In
Caucasians, AC occurred more often than SCC (84% versus
47%, resp.; P = .004). Adenocarcinoma was also much more
common in males (86%) than SCC (47%; P = .0007). The
AC patients were slightly younger (59 versus 63) than those
in the SCC group (P = .21) (Table 1).
Patients in the SCC group were signiﬁcantly more likely
to have a history of alcohol abuse (8/21, 38.1%) versus those
in the AC group (6/52, 11.5%; P = .012). They were also
more likely to have a history of pulmonary disease (asthma,
COPD, pneumonia) than the AC group (23.8% versus
5.77%; P = .034). Interestingly, there was no diﬀerence in
the rate of COPD between the two groups (2.8% versus
3.9%; P = .133) and no diﬀerence in rates of tobacco use
(61.9% versus 69.2%; P = .5492), mean pack years (56.6%
versus 51.0%; P = .573), or prior cardiac disease history
(CAD, atrial ﬁbrillation, prior MI, or percutaneous coronary
intervention (PCI); 19.1% versus 25.1%; P = .5806). At the
time of operation, median estimated blood loss was similar
for both groups (551mL for AC and 600mL for SCC, P =
.7626).
In the AC group, there were two (3.9%) patients with in
situ disease, ﬁve (9.8%) with T0 disease, ﬁve (9.8%) T1s, 10
(19.6%) T2s, 27 (52.9%) with T3 disease, and 2 (3.9%) with
T4 disease on ﬁnal pathology (Table 2). The SCC group had
a similar distribution: 2 (9.5%) T0s, 4 (19.0%) T1s, 2 (9.5%)
T2s, 9 (42.8%) T3s, and 4 (19.1%) T4s; the diﬀerences wereJournal of Oncology 3
Table 2: Adenocarcinoma and squamous cell carcinoma tumor features and perioperative data.
Adenocarcinoma, n (%) Squamous cell carcinoma, n (%) P-value
Ts t a g e .2032
T0 5 (9.80%) 2 (9.52%)
Tis 2 (3.92%) 0
T1 5 (9.80%) 4 (19.05%)
T2 10 (19.61%) 2 (9.52%)
T3 27 (52.94%) 9 (42.86%)
T4 2 (3.92%) 4 (19.05%)
Ns t a g e .1933
N0 24 (47.06%) 14 (66.67%)
N1 25 (49.02%) 7 (33.33%)
N2 2 (3.92%) 0
Neoadjuvant therapy 18 (34.62%) 9 (42.86%) .5114
Weight loss 29 (55.77%) 13 (61.90%) .6301
Mean BMI 26.72 22.89 .0299
Mean PNI 33.61 33.00 .6921
Epidural anesthesia 44 (85%) 18 (87%) .78
Anastomosis .8892
Stapled 17 (33.33%) 6 (31.58%)
Sewn 34 (66.67%) 13 (68.42%)
Mean EBL 551.065 600.000 .7626
Margin Pos 1 (2%) 1 (4%) .08
Time from OP to extubation 0.5 (0–48) 1 (0–72) .86
Complications 34 (65.38%) 18 (85.71%) .0693
Grade of complications .0053
1 or 2 15 (44.12%) 6 (35.29%)
3, 4, or 5 19 (55.88%) 11 (64.71%)
ICU stay >3 days 23 (47.92%) 16 (76.19%) .0259
not signiﬁcant (P = .2). Nodal staging for the AC group
consisted of 24 patients (47%) with N0 disease, 25 (49%)
with N1 disease, and 2 (3.9%) patients with N2 disease.
In the SCC group, there were 14 (66.7%) with N0 disease
and 7 (33.3%) with N1 disease. There were no patients
with N2 disease in the SCC group. The diﬀerences were
not statistically signiﬁcant (P = .25). Metastatic disease was
found in one patient in each group (P = .5).
The use of neoadjuvant chemoradiation between the
AC and SCC groups was similar. Overall, 36% of patients
receivedpreoperativetherapy:18 (34%)oftheACgroupand
9 (42%) of the SCC group (P = .5). A similar proportion of
patients in each group had experienced weight loss prior to
undergoing operative therapy: 55.7% (29) of AC and 61.9%
(13) of SCC. There was a trend in patients with AC to have a
BMI greater than 20, while patients with SCC tended to have
a BMI less than 20 (P = .056). The diﬀerence in mean BMI
among groups was signiﬁcant, however. In the AC group, the
mean was 26.7 while in the SCC group it was 22.889 (P =
.0299). Also, female patients tended to have a decreased BMI
(81.2%) versus male patients (36.7%); this was signiﬁcant
(P = .002) as well. The African-American patients also had
lower BMI (80% less than 20) than Caucasians (42.8% less
than 20; P = .06).
There were 65 independently identiﬁed complications
among 52 of the 73 patients comprising the cohort (Table 3).
Complications were graded on the basis of an established
scale. Seventy percent of patients experienced some sort of
complication: 9 (12%) were grade 1, 12 (16%) were grade
2, 23 (31.5%) were grade 3, 1 (1%) was grade 4, and 6
(8%) were grade 5. The grade 5 complications included
the three aforementioned deaths. The rate of complications
between the AC and SCC groups (65.4% versus 85.7%)
approached statistical signiﬁcance (P = .0693). However,
when the patients with no complications were excluded, the
distribution of the most severe complication in each patient
(grade 1 or 2 versus grade 3, 4, or 5) revealed a statistically
signiﬁcant disproportion with more severe complications
occurring the SCC group versus the AC group (64.7%
versus 55.9%, P = .0053). No diﬀerence existed among
races or genders in complications. Pulmonary complications
(including pneumonia) were the most predominant, com-
prising 29.3% of all complications. These were most strongly
associated with prior cardiac disease (P = .056), and not
with prior COPD history (P = .225), pulmonary history
(P = .336), histologic subtype (P = .503), or increasing
pack-year history of tobacco (P = .609). Esophageal leak
(a grade 3 complication) was the second most common4 Journal of Oncology
complication, with 10 (13.7%) occurrences. There was no
signiﬁcant diﬀerence in leak rate among histologic groups
(P = .805) or anastomosis type (P = .965).
Among the patients in the SCC group, the median PNI
was40.95(range27.56to61.36);intheACgroupthemedian
was 39.78 (range 27.75 to 57.16; P = .6983). PNI did not
appear to aﬀect morbidity. In the group of patients with a
PNI less than 40, there was a complication rate of 70.83%;
in those with a PNI greater than 40, the rate was 79.17%
(P = .5042). The distribution by grade of complications was
equivalent between those patients with a PNI of greater than
40 versus those with a PNI less than 40 (P = .9986). Patients
withaPNIlessthan40werealsonotanymorelikelytohavea
major(grade 3,4, or5)complicationversusthose witha PNI
greater than 40 (P = .9396). The diﬀerences in distributions
of pulmonary (P = .7452) and anastomotic leak (P =
.1501) were also not statistically signiﬁcant between the PNI
groups.
Despite the similarities among the groups in total
complications, SCC patients were more likely to have a 3-
day or longer ICU stay than AC patients (P = .004). The
higher incidence of pulmonary disease in these patients was
the largest contributor to this ﬁnding (P = .0016). However,
prior tobacco use (P = .8254), total pack years (P = .1286)
or cardiac disease (P = .5803) were not associated with a
prolonged ICU course. SCC was more likely in patients and
60 years of age (P = .004) but age was not an independent
factor for prolonged ICU stay.
4. Discussion
Advances in technique and patient care have lead to overall
decreases in esophagectomy mortality in the last 5 years
[8]. However, morbidity remains high (60% in some series)
and appears to be associated with tumor histology. Thus
the aim of the present study was to delineate the role of
tumor histology in regards to perioperative morbidity and
possibly preoperative decision making. Our study suggests
that tumor histology may be a signiﬁcant predictor of
morbidity, primarily as a surrogate for increased pulmonary
complications. These ﬁndings are supported by a similar
study from the United Kingdom [9], and might function as
an adjunct to other prognostic scoring systems [10].
Despite advances in surgical technique and perioperative
care, the types of complications in esophageal cancer are
fairly consistent [11]( Table 4). Pulmonary morbidity and
anastomotic leaks remain the most common [12]; both of
which can signiﬁcantly eﬀect a patient’s long-term quality
of life [13] when they occur. Pulmonary complications con-
tribute to most cases of mortality in esophageal cancer and
activeeﬀortstominimizetheireﬀectshavebeenattributedas
one of the most signiﬁcant causes of decreased perioperative
mortality[14].Thehistoricallydreadedanastomoticleakhas
been delegated to a lesser standing; this is in large part due
to new minimally invasive endoscopic techniques that have
been described for the management of leaks [15], making
what was once a devastating problem somewhat more easily
managed and no longer a source of increased mortality or
decreased long-term survival [16]. However, the pulmonary
Table 3: All inhospital and 90-day postoperative complications and
grade by histology.
Complication Adeno SCC
n 34/52
(65%)
17/21
(81%)
Grade 1: 6 3
Pneumonia — 1
Fever 1 1
Partial cord paralysis — 1
Anastomotic leak 1 —
Hypertension 1 —
Decubitus ulcer 1 —
Hypovolemia 1 —
Urinary tract infection 1 —
Grade 2: 9 3
Fever 1 1
Mediastinitis — 1
Prolonged enteral feeding — 1
Excessive pain 1 —
Pneumonia 2 —
Pleural eﬀusion 1 —
Readmission 1 —
Anastomotic leak 1 —
Atrial ﬁbrillation 2 —
Grade 3: 15 8
Pleural eﬀusion, pneumonia — 1
Anastomotic leak, EtOH withdrawal — 1
Anastomotic leak, pleural eﬀusion — 1
Anastomotic leak 3 2
Delayed gastric emptying — 1
Pleural eﬀusion 1 1
Respiratory compromise 1 1
Confusion, esophageal leak 1 —
Confusion, pneumonia, respiratory failure 1 —
Pleural eﬀusion, atelectasis 1 —
Anastomotic leak, pneumonia 1 —
Anastomotic leak, pneumonia, SVT 1 —
Anastomotic leak, evisceration 1 —
Anastomotic leak, paraesophageal hernia 1 —
SVT 1 —
Pneumonia 1 —
Hemorrhage 1 —
Grade 4: 1 0
Anastomotic leak 1 —
Grade 5: 3 3
Anastomotic leak — 1
Pneumonia — 1
Pulmonary embolus 1 —
Death 2 1Journal of Oncology 5
Table 4: Recent studies of morbidity in SCC patients undergoing esophagectomy.
Author Year n SCC % SCC approach SCC
pulmonary
SCC anastomotic
leak
SCC median
EBL (mL)
SCC ICU
stay (days)
SCC
mortality
Whooley 2001 710 100% TTE (100%) 32% 3.5% 832 — 11%
Ferguson 2002 290 34.5% — 39% — — — —
Fang 2003 441 >90% 3 Field (100%) 7.3% 32.65% 587.5–642.1 — 2.5%
Law 2004 421 100% TTE (83%) 15.9% 3.1% 700 — 1.4%
Alexiou 2006 621 31.72% TTE (55%) 18.3% 8.6% — — 8.1%
Woodall 2007 73 29% TTE (100%) 28.57% 26.32% 600 6 0%
p r o b l e m sa r em o r ed i ﬃcult in a population in which, at least
inthe caseof SCC, patients are more likely tobe smokers and
thus more likely to carry a diagnosis of underlying COPD.
This was likely the root cause of the prolonged intensive care
unit stays seen in the SCC cohort in this study.
The perioperative risks for patients with COPD are
well known [17]. However, age, operative duration, and
proximal tumor location have also been identiﬁed as factors
contributing to pulmonary morbidity [18], of which all
are more likely to be associated with SCC histology than
AC. Despite an eﬃcient resection, patients who suﬀer
complications are at increased risk of surgical oncotaxis
[19], the acceleration of their disease caused by opera-
tive factors. The patients reported in this study by Hirai
et al. had earlier metastasis and poorer long-term out-
comes. Therefore, at least from one study, minimizing
morbidity is important not only from a short-term peri-
operative perspective but also from a long-term cancer
prognosis standpoint. Although it should be noted that
another study, by Ferri et al., showed an increased short-
term mortality in SCC patients suﬀering a complication,
there are no long-term eﬀects in those that survived [20].
Nutrition remains the focus in many studies of
esophagectomy, but its role in morbidity is somewhat
unclear. Few other malignancies aﬀect the nutritional status
of the patient prior to diagnosis more than esophageal
cancer, and are thus a potential powerful marker of surgical
outcome. Most surgeons would associate esophageal cancer
with malnutrition, noting the diminution in the ability of
the patient to take in adequate calories in addition to the
wasting normally seen with other malignancies, and thus
try to supplement feedings. Advocates of this approach
stress the beneﬁts of preoperative enteral supplementation.
The perioperative advantages of this were identiﬁed in a
paper by Nozoe demonstrating decreased complications and
better long-term survival in patients with higher prognostic
nutritional index (PNI), a mathematical computation of the
patients albumin and absolute lymphocyte count [21]. As
discussed by Onodera in the initial description of PNI, a
minimum value of 40 is recommended prior to undertaking
an esophageal resection. In the present study, a PNI of less
than 40 did not adversely aﬀect outcomes and led to no
increase in morbidity.
At the opposing end of the spectrum, increasing BMI
has been attributed to the increasing incidence of AC. Even
signiﬁcantly, overweight patients may be relatively catabolic
and consideration for supplementation should be given in
this population as well. Fortunately, increasing patient BMIs
has not been associated with poorer operative or disease
related outcomes. Also, in at least one large study of 400
patients, nutritional status as determined by BMI, PNI,
weight loss, and other factors had no value in predicting
perioperative complications [22].
Overtime,multimodalitytreatmentofesophagealcancer
has improved, oﬀering increased long-term survival [23].
Betterresultshavebeennotedforfactorsmostwouldidentify
as predictive of long-term success in any cancer, including
low AJCC stage, R0 resection, and M0 status. Neoadjuvant
therapy is gaining acceptance, as it can be given safely,
is generally better tolerated than adjuvant therapy, and
does not aﬀect operative morbidity or mortality. SCC can
be treated safe and eﬀectively with multimodality therapy,
providing durable results even for patients with positive
nodal disease as well as those from Asian studies discovered
to have early tumors. Regardless of the physician’s opinion
in regards to the timing of additional therapy, most agree
that esophageal squamous and adenocarcinoma are not
purely surgically treated diseases and that some form of
multimodality treatment is needed to extend quality of life
time. Therefore, from a surgical perspective, optimizing
patient selection and operative technique are important
so that patients may recover quickly and go on to their
additional therapy.
Technical advances have allowed for reﬁnement in the
techniques in esophageal surgery to reduce perioperative
morbidity and mortality [24]. What technology to apply on
a case-to-case basis is a somewhat more diﬃcult question
to answer. Recent studies have also served to benchmark
expected courses for patients with AC, and the outcomes
for all esophageal resections has improved signiﬁcantly [25].
Because of this, any changes in techniques or approach
need to be critically reviewed. Choice of operative approach
has been extensively studied, but until recently has focused
on the transhiatal versus transthoracic approach [2]o r
technical factors such as the location of the conduit in
the mediastinum. With the public’s growing interest in
minimallyinvasiveapproaches,coupledwithnewtechniques
and instrumentation, minimally invasive esophagectomy has
been proven safe and feasible both in the United States
and abroad [3]. It also does not adversely aﬀect long-
term survival, a question that has been repeatedly raised
when laparoscopic approaches are used to address surgical6 Journal of Oncology
oncology diagnoses. The diﬃculty is that there are a variety
of techniques and combinations of approaches reported as
“minimally invasive,” with no standardized deﬁnition and
any real beneﬁt over traditional techniques has yet to be
proven. Most advocates of this approach perceive decreased
pulmonary morbidities and improved pulmonary therapy as
the main advantages, but some studies have questioned this
beneﬁt. Preoperative pulmonary evaluations have tended to
focus on pulmonary factors alone, including smoking and
COPD. However, given these factors in a high-risk subgroup
(SCC), there might be more of an advantage for minimally
invasive techniques and perhaps we should evaluate these
patients for this approach.
The limitations of this study are the small sample size
of the SCC patients. This limits the impact of the data
presented, but does not limit the fact that these two types of
histologies are both biologically diﬀerent and physiologically
diﬀerent and treating physicians should be aware of these
diﬀerences and the impact that these play on perioperative
outcomes.
5. Conclusion
The presence of SCC was the single best predictor of
prolonged intensive care unit stay and more severe com-
plications as deﬁned by this study. Only a past history of
pulmonary disease was diﬀerent between the two histologic
subgroups. No other factor, including sex, gender, age, or
nutritional status was predictive of this outcome. Esophageal
histology should therefore be considered in the perioperative
care of patients and may in the future be used to guide
operative strategies.
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